A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus
Journal of Diabetes · 2025-08 · 17 (8)
DOI: 10.1111/1753-0407.70120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 06.08.2025. Verfasst von Yazdan Ebrahimpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disorder where the immune system targets and destroys insulin‐producing β‐cells in the pancreas. It generally emerges during childhood or adolescence, but individuals of any age can be affected. In contrast to Type 2 diabetes mellitus (T2DM) which is often associated with lifestyle factors, T1DM cannot be prevented and necessitates lifelong management. Currently, there is no definitive cure for T1DM, and patients rely on continuous insulin injections for their entire lives. Ongoing developments in insulin treatment, such as insulin pumps, continuous glucose monitoring, and hybrid closed‐loop systems, offer promising alternatives. Despite advancements in intensive glycemic control that have reduced the occurrence of microvascular and macrovascular complications, a significant number of T1DM patients still these issues. Extensive research efforts are crucial to achieve early detection, prevent the loss of β‐cells, and devise improved treatment strategies to enhance the quality of life and prognosis for those affected. This review explores the most noteworthy and recent advancements in the field of T1DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
- Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
ORCID-Profile: Yazdan Ebrahimpour
Zitieren
APA
Ebrahimpour, Y., Khatami, S., Saffar, M., Fereidouni, A., Biniaz, Z., Erfanian, N., & Fereidouni, M. (2025). A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus. Journal of Diabetes, 17(8). https://doi.org/10.1111/1753-0407.70120
Vancouver
Ebrahimpour Y, Khatami S, Saffar M, Fereidouni A, Biniaz Z, Erfanian N, et al. A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus. Journal of Diabetes. 2025;17(8). doi:10.1111/1753-0407.70120
BibTeX
@article{Ebrahimpour2025,
author = {Ebrahimpour, Yazdan and Khatami, Sahbasadat and Saffar, Mahsa and Fereidouni, Alireza and Biniaz, Zahra and Erfanian, Nafiseh and Fereidouni, Mohammad},
title = {A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus},
journal = {Journal of Diabetes},
year = {2025},
volume = {17},
number = {8},
doi = {10.1111/1753-0407.70120}
}
EUVIMED